Private Equity Firm Financial Services

H2 Equity Partners

London, England, United Kingdom

H2 Equity Partners is a value-add private equity investment firm founded in 1991. It invests in mid-sized, profitable companies in the UK and Ireland and works with management to drive growth and operational improvement.

Focus Areas
Private Equity (Value-Add)
Website
www.h2ep.co.uk

Tracked deals

3

3 tracked deals across 2020-2026.

Recent pace

1

1 tracked deal announced in the last 12 months.

Deal mix

Addon

1 addon · 1 buyout · 1 growth capital

H2 Equity Partners Acquisition Volume by Year

Last 3 years

Acquisition volume by year Annual acquisition counts for the last 3 years for H2 Equity Partners. 1 2020 1 2022 ~1 est. 1 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

  • Buyer
    H2 Equity Partners
    Target
    Metals and Additives, William Blythe
    Industry
    Manufacturing
    Type
    Addon

    H2 Equity Partners backed Metals and Additives, then combined it with William Blythe to create an international specialty chemicals platform. The merged platform focuses on regulated and mission-critical applications, with particular strengths in flame retardants and smoke suppressants across North America, Europe, and Asia.

  • Buyer
    H2 Equity Partners
    Target
    Motive Offshore Group
    Seller
    EV Private Equity
    Industry
    Energy
    Location
    Scotland, United Kingdom

    H2 Equity Partners has made a multimillion-pound growth investment in Motive Offshore Group to support the company's international expansion and accelerate its shift into renewables. The deal adds two H2 representatives to Motive's executive board, replaces previous investor EV Private Equity and will fund continued M&A, fleet expansion and digitalisation of equipment and services.

  • Buyer
    H2 Equity Partners
    Target
    Optegra International Limited
    Location
    United Kingdom
    Type
    Buyout

    H2 Equity Partners has exchanged contracts to acquire Optegra International Limited, a pan‑European ophthalmology group operating 23 eye hospitals across the United Kingdom, Czech Republic and Poland. Completion is subject to regulatory conditions and expected early 2021; H2 will partner with CEO Dr Peter Byloos and management to execute Optegra's growth strategy and expand its eye‑care services.

Related Acquisition Pages

Selling a company? Get in front of buyers like H2 Equity Partners

Turn tracked acquisition activity into an outreach-ready buyer list.